Protein study of cervical neuroendocrine tumors
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at the proteins in cervical neuroendocrine tumors to understand how they behave and how they affect long-term outcomes. It aims to find new markers that could help predict prognosis and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of cervical neuroendocrine carcinoma (a rare type of cervical cancer).
- Your clinical records (test results, treatment history) must be complete.
- You must have been treated at Fujian Maternity and Child Health Hospital.
- Follow-up information must be available to track your health after treatment.
- A tumor tissue sample (paraffin block) must be available and of good quality for protein testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at epigenomic markers in different types of neuroendocrine tumors and cancers to find better ways to diagnose and treat them. It may help if you have a neuroendocrine tumor or certain other gastrointestinal cancers that can be surgically removed or biopsied.
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
This trial tests whether additional therapy after surgery can help people with a rare type of cervical cancer called gastric-type adenocarcinoma. It aims to find better ways to keep the cancer from coming back for those who have certain risk factors.
This study looks at whether certain markers in your blood (DNA from cancer cells and HPV) can help predict how well you do after first treatment for cervical cancer that has come back or spread. You would have extra blood draws during follow-up visits.
This study tests a combination of immunotherapy (dostarlimab), chemotherapy (cisplatin and etoposide), and radiation to treat small cell neuroendocrine cervical cancer. The goal is to see if this approach works better and is safe for people who haven't had treatment yet.
This study follows people diagnosed with a rare type of cervical cancer called large cell neuroendocrine carcinoma. Researchers want to learn more about how this cancer behaves and how patients respond to treatment over time.
Hear when a new Neuroendocrine Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.